Hannah Davis Selected Research

Hannah Davis Research Topics

2	Infections 01/2023 - 04/2016
2	Neoplasms (Cancer) 01/2022 - 01/2021
1	COVID-19 01/2024
1	Post-Acute COVID-19 Syndrome 01/2024
1	Reinfection 01/2023
1	Heart Failure 01/2023
1	Deglutition Disorders (Dysphagia) 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Ischemic Stroke 01/2022
1	Neurodevelopmental Disorders 01/2022
1	Osteoporosis 01/2017
1	Lung Diseases (Lung Disease) 04/2016
1	Acute Kidney Injury (Acute Renal Failure) 04/2016

1	SARS-CoV-2 spike proteinIBA 01/2024
1	COVID-19 VaccinesIBA 01/2024
1	Immunoglobulin G (IgG)IBA 01/2024
1	VaccinesIBA 01/2024
1	AlbuminsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2023
1	Eplerenone (Inspra)FDA LinkGeneric 01/2023
1	gamma-Aminobutyric Acid (GABA)IBA 01/2022
1	Tenecteplase FDA Link 01/2022
1	Tranexamic Acid (AMCA)FDA Link 01/2022
1	Parathyroid Hormone (Parathormone)IBA 01/2017
1	Minocycline (Cyclops)FDA LinkGeneric 04/2016
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 04/2016

2	Radiotherapy 01/2022 - 01/2021
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Therapeutics 01/2017